Found: 149
Select item for more details and to access through your institution.
Clinical and Radiologic Predictors of Response to Atezolizumab-Bevacizumab in Advanced Hepatocellular Carcinoma.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 4, p. 1219, doi. 10.4143/crt.2024.283
- By:
- Publication type:
- Article
Clinical Outcomes of Surgery after Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Ductal Adenocarcinoma.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 4, p. 1240, doi. 10.4143/crt.2023.977
- By:
- Publication type:
- Article
Clinical outcomes of immune checkpoint inhibitors in unresectable or metastatic combined hepatocellular–cholangiocarcinoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 10, p. 7547, doi. 10.1007/s00432-023-04704-3
- By:
- Publication type:
- Article
Regorafenib versus cabozantinb as second-line treatment after sorafenib for unresectable hepatocellular carcinoma: matching-adjusted indirect comparison analysis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 12, p. 3665, doi. 10.1007/s00432-021-03602-w
- By:
- Publication type:
- Article
Multiparametric MRI for prediction of treatment response to neoadjuvant FOLFIRINOX therapy in borderline resectable or locally advanced pancreatic cancer.
- Published in:
- European Radiology, 2021, v. 31, n. 2, p. 864, doi. 10.1007/s00330-020-07134-8
- By:
- Publication type:
- Article
Real-world data analysis of patients with cancer of unknown primary.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-02543-1
- By:
- Publication type:
- Article
Clinical outcomes of patients with resectable pancreatic acinar cell carcinoma.
- Published in:
- Journal of Digestive Diseases, 2017, v. 18, n. 8, p. 480, doi. 10.1111/1751-2980.12505
- By:
- Publication type:
- Article
Rivaroxaban Versus Low-molecular-weight Heparin for Venous Thromboembolism in Advanced Upper Gastrointestinal Tract and Hepatopancreatobiliary Cancer.
- Published in:
- In Vivo, 2020, v. 34, n. 2, p. 829, doi. 10.21873/invivo.11845
- By:
- Publication type:
- Article
Reduced and Normalized Carbohydrate Antigen 19-9 Concentrations after Neoadjuvant Chemotherapy Have Comparable Prognostic Performance in Patients with Borderline Resectable and Locally Advanced Pancreatic Cancer.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 5, p. 1477, doi. 10.3390/jcm9051477
- By:
- Publication type:
- Article
Multicenter phase II study of oral capecitabine plus irinotecan as first-line chemotherapy in advanced colorectal cancer: A Korean Cancer Study Group Trial.
- Published in:
- Acta Oncologica, 2005, v. 44, n. 3, p. 230, doi. 10.1080/02841860510029590
- By:
- Publication type:
- Article
Real-world efficacy and safety of cabozantinib in Korean patients with advanced hepatocellular carcinoma: a multicenter retrospective analysis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221097934
- By:
- Publication type:
- Article
Real-world outcomes of adjuvant gemcitabine versus gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221097190
- By:
- Publication type:
- Article
Prognostic Relevance of p53 Overexpression in Gastrointestinal Stromal Tumors of the Small Intestine: Potential Implication for Adjuvant Treatment with Imatinib.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2015, v. 22, p. 362, doi. 10.1245/s10434-015-4506-3
- By:
- Publication type:
- Article
Intraoperatively Assessed Macroscopic Serosal Changes in Patients with Curatively Resected Advanced Gastric Cancer: Clinical Implications for Prognosis and Peritoneal Recurrence.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2015, v. 22, n. 9, p. 2940, doi. 10.1245/s10434-014-4352-8
- By:
- Publication type:
- Article
The Role of Surgical Resection Following Imatinib Treatment in Patients with Recurrent or Metastatic Gastrointestinal Stromal Tumors: Results of Propensity Score Analyses.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2014, v. 21, n. 13, p. 4211, doi. 10.1245/s10434-014-3866-4
- By:
- Publication type:
- Article
The Effects of Surgical Cytoreduction Prior to Imatinib Therapy on the Prognosis of Patients with Advanced GIST.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2013, v. 20, n. 13, p. 4212, doi. 10.1245/s10434-013-3279-9
- By:
- Publication type:
- Article
Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing first-line gemcitabine-containing therapy: effect of performance status and comparison with other regimens.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Serum CA 19-9 as a prognostic factor in patients with metastatic gastric cancer.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2013, v. 9, n. 4, p. 324, doi. 10.1111/ajco.12019
- By:
- Publication type:
- Article
Phase II study of S-1 and irinotecan combination chemotherapy as a first-line therapy for patients with advanced gastric cancer. Korean Cancer Study Group Protocol ST05-02.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2009, v. 5, n. 1, p. 46, doi. 10.1111/j.1743-7563.2009.01191.x
- By:
- Publication type:
- Article
A phase 1 study of oral ASP5878, a selective small-molecule inhibitor of fibroblast growth factor receptors 1–4, as a single dose and multiple doses in patients with solid malignancies.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 2, p. 445, doi. 10.1007/s10637-019-00780-w
- By:
- Publication type:
- Article
Efficacy and safety of lanreotide in Korean patients with metastatic, well-differentiated gastroenteropancreatic-neuroendocrine tumors: a retrospective analysis.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 4, p. 763, doi. 10.1007/s10637-018-0710-x
- By:
- Publication type:
- Article
Multicenter retrospective analysis of the safety and efficacy of regorafenib after progression on sorafenib in Korean patients with hepatocellular carcinoma.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 3, p. 567, doi. 10.1007/s10637-018-0707-5
- By:
- Publication type:
- Article
Prognostic factors in patients with metastatic or recurrent pancreatic cancer treated with first-line nab-paclitaxel plus gemcitabine: implication of inflammation-based scores.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 3, p. 584, doi. 10.1007/s10637-018-0681-y
- By:
- Publication type:
- Article
Phase I/II study of first-line combination therapy with sorafenib plus resminostat, an oral HDAC inhibitor, versus sorafenib monotherapy for advanced hepatocellular carcinoma in east Asian patients.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 6, p. 1072, doi. 10.1007/s10637-018-0658-x
- By:
- Publication type:
- Article
Nab-paclitaxel plus gemcitabine versus FOLFIRINOX as the first-line chemotherapy for patients with metastatic pancreatic cancer: retrospective analysis.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 4, p. 732, doi. 10.1007/s10637-018-0598-5
- By:
- Publication type:
- Article
Germline <italic>BRCA</italic> mutations in Asian patients with pancreatic adenocarcinoma: a prospective study evaluating risk category for genetic testing.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 1, p. 163, doi. 10.1007/s10637-017-0497-1
- By:
- Publication type:
- Article
Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with regorafenib.
- Published in:
- Hepatology Research, 2021, v. 51, n. 7, p. 796, doi. 10.1111/hepr.13669
- By:
- Publication type:
- Article
Phase 1/2a Study of Rivoceranib, a Selective VEGFR-2 Angiogenesis Inhibitor, in Patients with Advanced Solid Tumors.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 3, p. 743, doi. 10.4143/crt.2023.980
- By:
- Publication type:
- Article
Analysis of Plasma Circulating Tumor DNA in Borderline Resectable Pancreatic Cancer Treated with Neoadjuvant Modified FOLFIRINOX: Clinical Relevance of DNA Damage Repair Gene Alteration Detection.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 4, p. 1313, doi. 10.4143/crt.2023.452
- By:
- Publication type:
- Article
Survival Benefit of Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Surgery Following Neoadjuvant FOLFIRINOX.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 3, p. 956, doi. 10.4143/crt.2022.409
- By:
- Publication type:
- Article
Adjuvant Chemotherapy for Resected Ampulla of Vater Carcinoma: Retrospective Analysis of 646 Patients.
- Published in:
- Cancer Research & Treatment, 2021, v. 53, n. 2, p. 424, doi. 10.4143/crt.2020.953
- By:
- Publication type:
- Article
Spatial Distribution and Prognostic Implications of Tumor-Infiltrating FoxPS<sup>-</sup> CD4<sup>+</sup> T Cells in Biliary Tract Cancer.
- Published in:
- Cancer Research & Treatment, 2021, v. 53, n. 1, p. 162, doi. 10.4143/crt.2020.704
- By:
- Publication type:
- Article
Systemic Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors in Korea: Literature Review and Expert Opinion.
- Published in:
- Cancer Research & Treatment, 2021, v. 53, n. 2, p. 291, doi. 10.4143/crt.2020.1233
- By:
- Publication type:
- Article
Efficacy and Safety of Pembrolizumab in Patients with Refractory Advanced Biliary Tract Cancer: Tumor Proportion Score as a Potential Biomarker for Response.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 2, p. 594, doi. 10.4143/crt.2019.493
- By:
- Publication type:
- Article
Clinical Outcomes of Second-Line Chemotherapy after Progression on Nab-Paclitaxel Plus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 1, p. 254, doi. 10.4143/crt.2019.190
- By:
- Publication type:
- Article
Clinical Benefit of Maintenance Therapy for Advanced Biliary Tract Cancer Patients Showing No Progression after First-Line Gemcitabine Plus Cisplatin.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 3, p. 901, doi. 10.4143/crt.2018.326
- By:
- Publication type:
- Article
Phase I Dose-Finding Study of OPB-111077, a Novel STAT3 Inhibitor, in Patients with Advanced Hepatocellular Carcinoma.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 2, p. 510, doi. 10.4143/crt.2018.226
- By:
- Publication type:
- Article
Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-Line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer.
- Published in:
- Cancer Research & Treatment, 2018, v. 50, n. 4, p. 1324, doi. 10.4143/crt.2017.526
- By:
- Publication type:
- Article
Prognosis of Pancreatic Cancer Patients with Synchronous or Metachronous Malignancies from Other Organs Is Better than Those with Pancreatic Cancer Only.
- Published in:
- Cancer Research & Treatment, 2018, v. 50, n. 4, p. 1175, doi. 10.4143/crt.2017.494
- By:
- Publication type:
- Article
Efficacy and Safety of Regorafenib in Korean Patients with Advanced Gastrointestinal Stromal Tumor after Failure of Imatinib and Sunitinib: A Multicenter Study Based on the Management Access Program.
- Published in:
- Cancer Research & Treatment, 2017, v. 49, n. 2, p. 350, doi. 10.4143/crt.2016.067
- By:
- Publication type:
- Article
Real-Life Experience of Sorafenib Treatment for Hepatocellular Carcinoma in Korea: From GIDEON Data.
- Published in:
- Cancer Research & Treatment, 2016, v. 48, n. 4, p. 1243, doi. 10.4143/crt.2015.278
- By:
- Publication type:
- Article
Efficacy of Imatinib in Patients with Platelet-Derived Growth Factor Receptor Alpha-Mutated Gastrointestinal Stromal Tumors.
- Published in:
- Cancer Research & Treatment, 2016, v. 48, n. 2, p. 546, doi. 10.4143/crt.2015.015
- By:
- Publication type:
- Article
Severe Imatinib-Associated Skin Rash in Gastrointestinal Stromal Tumor Patients: Management and Clinical Implications.
- Published in:
- Cancer Research & Treatment, 2016, v. 48, n. 1, p. 162, doi. 10.4143/crt.2015.017
- By:
- Publication type:
- Article
ALBI score and outcomes in patients with hepatocellular carcinoma: post hoc analysis of the randomized controlled trial KEYNOTE-240.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211039928
- By:
- Publication type:
- Article
Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211003053
- By:
- Publication type:
- Article
ALBI score and outcomes in patients with hepatocellular carcinoma: post hoc analysis of the randomized controlled trial KEYNOTE-240.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211039928
- By:
- Publication type:
- Article
Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211003053
- By:
- Publication type:
- Article
FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920953294
- By:
- Publication type:
- Article
Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retrospective analysis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920923424
- By:
- Publication type:
- Article
Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study Group.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919871126
- By:
- Publication type:
- Article